Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Anatomic Stage II Breast Cancer AJCC v8 × tremelimumab × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Hepatocellular 23 Carcinoma, Non-Small-Cell Lung 11 Lung Neoplasms 6 Liver Neoplasms 6 Small Cell Lung Carcinoma 4 Diabetes Mellitus, Insulin-Dependent, 12 4 Cholangiocarcinoma 4 Urinary Bladder Neoplasms 3 Pancreatic Neoplasms 3 Ovarian Neoplasms 3 Fallopian Tube Neoplasms 3 Biliary Tract Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 2 Prostatic Neoplasms 2 Neoplasms 2 Neoplasm Metastasis 2 Mesothelioma, Malignant 2 Mesothelioma 2 Carcinoma 2 Adenocarcinoma Of Esophagus 2 Vulvar Neoplasms 1 Vascular Neoplasms 1 Vaginal Neoplasms 1 Uterine Cervical Neoplasms 1 Urothelial Cancer 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Unresectable Hepatocellular Carcinoma 1 Thyroid Neoplasms 1 Thyroid Cancer, Papillary 1

Interventions

trastuzumab biosimilar HLX02 2 pertuzumab 2 Trastuzumab 2 Taxes 2 Paclitaxel 2 PF-05280014 2 Ontruzant 2 Ogivri 2 Docetaxel 2 2C4 antibody 2 tucatinib 1 ribociclib 1 durvalumab 1 Surgical Procedures, Operative 1 Specimen Handling 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Conformal 1 Radiotherapy 1 Radiation 1 Mastectomy, Segmental 1 Mastectomy 1 Magnetic Resonance Spectroscopy 1 Immunoglobulin G 1 High-Energy Shock Waves 1 Genetic Testing 1 Fulvestrant 1 Fluorodeoxyglucose F18 1 Drug Therapy 1 Doxorubicin 1 Disulfides 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡